What we do/ Health Economics & Outcomes Research
Meaningful outcomes better decisions
Turning evidence into value, and value into better healthcare decisions.
What we do/ Health Economics & Outcomes Research
Demonstrating Value Through Health Economics & Outcomes Research
From evidence generation to value demonstration, we provide the health economics and outcomes research expertise needed to support informed healthcare and market access decisions.
We partner with pharmaceutical and biotechnology companies, medical device and diagnostic organizations, healthcare providers, payers, and scientific organizations to generate evidence that demonstrates clinical, economic, and patient value. Our flexible approach spans real-world evidence, economic evaluation, outcomes research, evidence synthesis, and value strategies to support reimbursement, market access, and healthcare decision-making.
Our Health Economics & Outcomes Research services support the full evidence-generation lifecycle, including real-world evidence studies, health economic evaluations, outcomes research, systematic literature reviews, evidence synthesis, burden-of-disease studies, patient-reported outcomes, HTA support, value demonstration, and market access strategy.
Our services
Evidence Strategy & Planning
Evidence Gap Analysis – Assessment of existing evidence and identification of priority gaps.
Integrated Evidence Generation Plan – Strategic roadmap defining what evidence should be generated, when, and for which decision needs.
Evidence Landscape Assessment – Mapping of available clinical, real-world, economic, and patient evidence.
Evidence Requirements Mapping – Assessment of evidence expectations across regulators, HTA bodies, payers, clinicians, and other stakeholders.
Evidence Prioritisation Framework – Structured prioritisation of studies and analyses based on strategic importance, feasibility, timing, and decision impact.
Evidence Generation Roadmap – Sequenced plan of studies, analyses, models, and publications across the product lifecycle.
RWE Strategy – Identification of real-world evidence needs, appropriate data sources, and study opportunities.
Evidence Strategy Workshop – Cross-functional workshop to align Medical, HEOR, Market Access, Clinical, and Commercial teams around evidence priorities.
Real-World Evidence & Outcomes Research
Real-World Evidence Study – Study design, analysis and reporting using appropriate real-world data.
Observational Study / Registry Analysis – Protocol, analysis and interpretation of observational evidence.
Epidemiology Study – Incidence, prevalence, natural history or population burden analysis.
Patient-Reported Outcomes Analysis – Analysis and interpretation of patient-reported or quality-of-life outcomes.
Statistical Analysis – Statistical analysis plan, outputs, interpretation and report.
Data Analysis & Decision Insight Report – Decision-focused analytical report translating data into actionable findings.
Cost-Effectiveness Models – Comparative costs and health outcomes.
Budget Impact Models – Financial impact of healthcare interventions on payers and health systems
Cost & Resource-Use Analyses – Healthcare utilization and associated costs.
Burden of Disease Studies – Epidemiological, resource, and economic burden.
Economic Evaluation Reports – Methods, assumptions, outcomes, uncertainty, and interpretation.
Model Adaptation & Localisation – Tailoring models to specific countries, payers, or decision contexts.
Scenario & Sensitivity Analyses – Assessing uncertainty and the impact of key assumptions.
Health Economics & Modelling
Value & Market Access Evidence
Value Proposition Development – Clear articulation of a product’s clinical, economic, and patient value.
Global & Local Value Dossiers – Integrated evidence packages supporting payer and HTA decision-making.
HTA Evidence Packages – Evidence development and synthesis aligned with HTA requirements.
Payer Evidence Strategy – Identification of evidence needed to support reimbursement and access.
Market Access Landscape Assessment – Evaluation of reimbursement pathways, evidence requirements, and access environments.
Payer & Stakeholder Research – Research into payer perspectives, evidence expectations, and decision drivers.
Value Message Development – Evidence-based messages communicating differentiated product value.
Reimbursement & Access Evidence Reports – Decision-focused synthesis of evidence relevant to pricing, reimbursement, and access.
Evidence Synthesis & Comparative Research
Systematic Literature Reviews – Structured identification, appraisal, and synthesis of available evidence.
Targeted Literature Reviews – Focused evidence reviews addressing specific research or decision questions.
Rapid Evidence Reviews – Accelerated synthesis of evidence to support time-sensitive decisions.
Meta-Analysis – Quantitative synthesis of outcomes across multiple studies.
Network Meta-Analysis – Indirect and mixed-treatment comparisons across multiple interventions.
Indirect Treatment Comparisons – Comparative effectiveness analyses where head-to-head evidence is unavailable.
Evidence Landscape Reviews – Mapping and synthesis of the existing evidence base.
Clinical & Comparative Evidence Reports – Integrated interpretation of comparative efficacy, safety, and other relevant outcomes.
Get in touch
To learn more about our Health Economics and Outcomes Research services and explore how we can support your next study, please get in touch with our team.
SERVICES
COMPANY
LEGAL AND GOVERNANCE